Page last updated: 2024-11-04

sulfasalazine and Pancreatic Diseases

sulfasalazine has been researched along with Pancreatic Diseases in 2 studies

Sulfasalazine: A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907)
sulfasalazine : An azobenzene consisting of diphenyldiazene having a carboxy substituent at the 4-position, a hydroxy substituent at the 3-position and a 2-pyridylaminosulphonyl substituent at the 4'-position.

Pancreatic Diseases: Pathological processes of the PANCREAS.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gall, DG1
Hamilton, JR1
Greenberger, NJ1
Saegh, S1
Ruppert, RD1

Reviews

1 review available for sulfasalazine and Pancreatic Diseases

ArticleYear
Chronic diarrhea in childhood: a new look at an old problem.
    Pediatric clinics of North America, 1974, Volume: 21, Issue:4

    Topics: Celiac Disease; Chlorides; Chronic Disease; Cystic Fibrosis; Diarrhea; Diet Therapy; Food Hypersensi

1974

Other Studies

1 other study available for sulfasalazine and Pancreatic Diseases

ArticleYear
Urine indican excretion in malabsorptive disorders.
    Gastroenterology, 1968, Volume: 55, Issue:2

    Topics: Celiac Disease; Crohn Disease; Diagnosis, Differential; Feces; Humans; Indican; Intestinal Absorptio

1968